| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6242075 | Respiratory Medicine | 2011 | 8 Pages |
Abstract
Montelukast assured protection against exercise-induced bronchoconstriction from the first through the eighth hour from thefirst day of treatment. However, individual susceptibility to protection was evident since some individuals were not protected at any time. We conclude that in clinical use individual responses to the drug should be carefully evaluated in the follow-up management.
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Diego G. Peroni, Lydia Pescollderungg, Marco Sandri, Iolanda Chinellato, Attilio L. Boner, Giorgio L. Piacentini,